Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results
Gerlinger, Christoph, Bamber, Luke, Leverkus, Friedhelm, Schwenke, Carsten, Haberland, Claudia, Schmidt, Gilda, Endrikat, Jan
Published in BMC research notes (14.01.2019)
Published in BMC research notes (14.01.2019)
Get full text
Journal Article
Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure
Watanabe-Fujinuma, Emi, Origasa, Hideki, Bamber, Luke, Roessig, Lothar, Toyoda, Tetsumi, Haga, Yuri, Gwaltney, Chad, Pieske, Burkert
Published in Health and quality of life outcomes (17.07.2020)
Published in Health and quality of life outcomes (17.07.2020)
Get full text
Journal Article
Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials
Kramer, Frank, Butler, Javed, Shah, Sanjiv J., Jung, Christian, Nodari, Savina, Rosenkranz, Stephan, Senni, Michele, Bamber, Luke, Cichos, Stephan, Dori, Chrysanthi, Karakoyun, Toeresin, Köhler, Gabriele Jenny, Patel, Kinjal, Piraino, Paolo, Viethen, Thomas, Chennuru, Praneeth, Paydar, Ayse, Sims, Jason, Clark, Richard, van Lummel, Rob, Müller, Alexandra, Gwaltney, Chad, Smajlovic, Salko, Düngen, Hans-Dirk, Dinh, Wilfried
Published in Digital biomarkers (01.05.2020)
Published in Digital biomarkers (01.05.2020)
Get full text
Journal Article
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study
Cohen, Alexander T, Katholing, Anja, Rietbrock, Stephan, Bamber, Luke, Martinez, Carlos
Published in Thrombosis and haemostasis (01.01.2017)
Published in Thrombosis and haemostasis (01.01.2017)
Get more information
Journal Article
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial
Armstrong, Paul W, Lam, Carolyn S. P, Anstrom, Kevin J, Ezekowitz, Justin, Hernandez, Adrian F, O’Connor, Christopher M, Pieske, Burkert, Ponikowski, Piotr, Shah, Sanjiv J, Solomon, Scott D, Voors, Adriaan A, She, Lilin, Vlajnic, Vanja, Carvalho, Francine, Bamber, Luke, Blaustein, Robert O, Roessig, Lothar, Butler, Javed
Published in JAMA : the journal of the American Medical Association (20.10.2020)
Published in JAMA : the journal of the American Medical Association (20.10.2020)
Get full text
Journal Article
Patient‐reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES‐PRESERVED) study
Filippatos, Gerasimos, Maggioni, Aldo P., Lam, Carolyn S.P., Pieske‐Kraigher, Elisabeth, Butler, Javed, Spertus, John, Ponikowski, Piotr, Shah, Sanjiv J., Solomon, Scott D., Scalise, Andrea‐Viviana, Mueller, Katharina, Roessig, Lothar, Bamber, Luke, Gheorghiade, Mihai, Pieske, Burkert
Published in European journal of heart failure (01.06.2017)
Published in European journal of heart failure (01.06.2017)
Get full text
Journal Article
Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism – The COSIMO study
Cohen, Alexander T., Maraveyas, Anthony, Beyer-Westendorf, Jan, Lee, Agnes Y.Y., Folkerts, Kerstin, Abdelgawwad, Khaled, De Sanctis, Yoriko, Fatoba, Samuel, Bamber, Luke, Bach, Miriam, Mantovani, Lorenzo G.
Published in Thrombosis research (01.10.2021)
Published in Thrombosis research (01.10.2021)
Get full text
Journal Article
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of pulmonary embolism; results from the EINSTEIN PE trial
Prins, Martin H, Bamber, Luke, Cano, Stefan J, Wang, Maria Y, Erkens, Petra, Bauersachs, Rupert, Lensing, Anthonie W.A
Published in Thrombosis research (01.02.2015)
Published in Thrombosis research (01.02.2015)
Get full text
Journal Article
Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism
van Bellen, Bonno, Bamber, Luke, Correa de Carvalho, Francine, Prins, Martin, Wang, Maria, Lensing, Anthonie W A
Published in Current medical research and opinion (01.05.2014)
Published in Current medical research and opinion (01.05.2014)
Get more information
Journal Article
Defining changes in physical limitation from the patient perspective: insights from the VITALITY‐HFpEF randomized trial
Butler, Javed, Spertus, John A., Bamber, Luke, Khan, Muhammad Shahzeb, Roessig, Lothar, Vlajnic, Vanja, Norquist, Josephine M., Anstrom, Kevin J., Blaustein, Robert O., Lam, Carolyn S.P., Armstrong, Paul W.
Published in European journal of heart failure (01.05.2022)
Published in European journal of heart failure (01.05.2022)
Get full text
Journal Article
Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis
Bamber, Luke, Wang, Maria Y, Prins, Martin H, Ciniglio, Cathleen, Bauersachs, Rupert, Lensing, Anthonie W A, Cano, Stefan J
Published in Thrombosis and haemostasis (01.10.2013)
Published in Thrombosis and haemostasis (01.10.2013)
Get more information
Journal Article
Rationale and Design of the VITALITY-HFpEF Trial
Butler, Javed, Lam, Carolyn S P, Anstrom, Kevin J, Ezekowitz, Justin, Hernandez, Adrian F, O'Connor, Christopher M, Pieske, Burkert, Ponikowski, Piotr, Shah, Sanjiv J, Solomon, Scott D, Voors, Adriaan A, Wu, Yi, Carvalho, Francine, Bamber, Luke, Blaustein, Robert O, Roessig, Lothar, Armstrong, Paul W
Published in Circulation. Heart failure (01.05.2019)
Published in Circulation. Heart failure (01.05.2019)
Get full text
Journal Article
Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist
Bamber, Luke, Muston, Dominic, McLeod, Euan, Guillermin, Anne, Lowin, Julia, Patel, Raj
Published in Thrombosis journal (11.06.2015)
Published in Thrombosis journal (11.06.2015)
Get full text
Journal Article
Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program
Bookhart, Brahim K, Haskell, Lloyd, Bamber, Luke, Wang, Maria, Schein, Jeff, Mody, Samir H
Published in Journal of medical economics (01.10.2014)
Published in Journal of medical economics (01.10.2014)
Get more information
Journal Article
Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey Study
Nguyen, Chi, Bamber, Luke, Willey, Vincent J, Evers, Thomas, Power, Thomas P, Stephenson, Judith J
Published in Patient preference and adherence (01.01.2023)
Published in Patient preference and adherence (01.01.2023)
Get full text
Journal Article
Patient-Reported Treatment Satisfaction with Oral Rivaroxaban Versus Standard Therapy in the Treatment of Acute Symptomatic Pulmonary Embolism
Prins, Martin, Bamber, Luke, Cano, Stefan, Wang, Maria, Lensing, Anthonie WA, Bauersachs, Rupert
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article